Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Novaccess Global Inc XSNX

NovAccess Global Inc. is a biopharmaceutical company, which develops immunotherapies to treat brain tumor patients in the United States. The Company specializes in research related to utilizing a patient’s own immune system to attack the cancer. Its dendritic cell-based immunotherapy utilizes a combination of Toll-like receptor adjuvants for an enhanced antitumor response. The therapy is designed to utilize the patient’s tumor antigens and immune cells, dendritic cells, in combination with TLR adjuvants to initiate an efficient antitumor immune response. This process includes obtaining the patients' tumor cells after surgery, and precursors cells that are matured into dendritic cells from peripheral blood. Its TLR-AD1 platform technology is a vaccine immunotherapy for the treatment of aggressive brain cancers, including glioblastoma and other high-grade gliomas. TLR-AD1 technology has a scope of use and is embodied in various different product lines for different clinical situations.


OTCPK:XSNX - Post by User

Bullboard Posts
Post by coloradonorthon Oct 06, 2009 9:53am
302 Views
Post# 16365634

XsunX Reports Progress on Expanded Business Develo

XsunX Reports Progress on Expanded Business Develo
To Our Valued Shareholders,

In last month's progress update we told you that our scientific staff had established full-time operations on-site with a hard disc drive (HDD) equipment manufacturer. In a subsequent press release we were pleased to announce that our HDD equipment partner is Intevac, Inc., the world's leading provider of magnetic media deposition equipment to the HDD industry.
In case you missed the news release announcing Intevac, please visit the News page on our website:
https://xsunx.com/news-archives.aspx

We stated in our August progress report that a September project goal was to begin testing an evolving evaporation source design that we plan to then adapt to existing high-rate processing tools from Intevac's extensive line of proven, world-class magnetic media and imaging systems.

Our progress has been consistent with that goal, and we began evaporating metal, analyzing results, and establishing deposition rates for both the evaporation source and sputtering tools. There are a number layers to the CIGS structure and for the next several months our work effort will be to analyze results and refine designs, leading to the combination of these designs within a tool set and the ability to deposit CIGS devices.

Over the past month we have received numerous questions from investors related to Intevac and the use of Intevac technologies for our announced CIGS manufacturing technology development. The easiest way to explain what we are doing is to first mention that two of the established methods for manufacturing a CIGS solar device are (1) sputtering and (2) sputtering combined with evaporation. Using sputtering technologies alone, it is possible to manufacture all of the layers necessary to make a CIGS device. However, industry research has shown that sputtering alone has not achieved the same efficiency milestones that have been achieved when sputtering is used in combination with evaporation techniques to make the CIGS device.

What we are working towards is to adapt process recipes for the deposition of the non-core solar absorbing and conversion layers to sputtering tools previously developed by Intevac. These sputtering tools have benefited from years of proven industrial use, and we are finding them to be highly adaptable to our needs and well suited for use in the solar field. Separately, and with a focus on establishing what we believe to be the basis for achieving higher conversion efficiencies, we are developing evaporation source technology to produce the CIGS core solar absorber. We plan to adapt these designs to other Intevac equipment leveraging numerous existing system features with the goal of reducing costs and time to market. To our knowledge the use and adaptation of HDD equipment in this hybrid manner for CIGS PV manufacturing applications is not available in the market today.













Bullboard Posts